2-Bromo-1,4-Naphthalenedione Promoting CD8+ T Cell Expansion and Inhibits Th1/Th17 Differentiation to Mitigate Experimental Autoimmune Encephalomyelitis
Ontology highlight
ABSTRACT: In this study, we aim to explore the therapeutic potential of 2-bromo-1,4-naphthalenedione (BrQ), a derivative of naphthalenedione, in experimental autoimmune encephalomyelitis (EAE), an animal model of MS, and to elucidate its underlying mechanisms.
ORGANISM(S): Mus musculus
PROVIDER: GSE271550 | GEO | 2024/07/06
REPOSITORIES: GEO
ACCESS DATA